Ceftriaxone modulates uptake activity of glial glutamate transporter-1 against global brain ischemia in rats

Journal of Neurochemistry

Volumn 132, Issue 2, 2015, Pages 194-205

  Hu, Yu Yan ^a   Xu, Jing ^a   Zhang, Min ^a   Wang, Dan ^a   Li, Li ^a   Li, Wen Bin ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Aging and Cognition Neuroscience Laboratory of Hebei Province   (China)

Author keywords

antisense oligodeoxynucleotides; ceftriaxone; glial glutamate transporter 1; global brain ischemia; glutamate uptake; rat

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CEFTRIAXONE; DIHYDROKAINIC ACID; VESICULAR GLUTAMATE TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID; KAINIC ACID; NEUROPROTECTIVE AGENT; SLC1A2 PROTEIN, RAT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MECHANISM; GLIA CELL; HIPPOCAMPAL CA1 REGION; IN VIVO STUDY; MALE; NERVE CELL NECROSIS; NEUROMODULATION; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RAT; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG SCREENING; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PYRAMIDAL NERVE CELL; RANDOMIZATION; TRANSPORT AT THE CELLULAR LEVEL; WISTAR RAT;

RATTUS;

ANIMALS; BIOLOGICAL TRANSPORT; BRAIN ISCHEMIA; CA1 REGION, HIPPOCAMPAL; CEFTRIAXONE; DRUG EVALUATION, PRECLINICAL; EXCITATORY AMINO ACID TRANSPORTER 2; GENE KNOCKDOWN TECHNIQUES; GLUTAMIC ACID; KAINIC ACID; MALE; NEUROPROTECTIVE AGENTS; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; PYRAMIDAL CELLS; RANDOM ALLOCATION; RATS; RATS, WISTAR; UP-REGULATION;

EID: 84921417419     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12958     Document Type: Article

References (40)

1. Apricõ K., Beart P. M., Lawrence A. J., Crawford D., and, O'Shea R. D., (2001) [(3)H](2S,4R)-4-Methylglutamate: a novel ligand for the characterization of glutamate transporters. J. Neurochem. 77, 1218-1225.
2. Apricò K., Beart P. M., Crawford D., and, O'Shea R. D., (2004) Binding and transport of [3H](2S,4R)-4-methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes. J. Neurosci. Res. 75, 751-759.
3. Beller J. A., Gurkoff G. G., Berman R. F., and, Lyeth B. G., (2011) Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro. Restor. Neurol. Neurosci. 29, 331-346.
4. Benveniste H., Drejer J., Schousboe A., and, Diemer N. H., (1984) Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J. Neurochem. 43, 1369-1374.
5. Chu K., Lee S. T., Sinn D. I., et al. (2007) Pharmacological induction of ischemic tolerance by glutamate transporter-1 (EAAT2) upregulation. Stroke 38, 177-182.
6. Danbolt N. C., (2001) Glutamate uptake. Prog. Neurobiol. 65, 1-105.
7. Doyle K. P., Simon R. P., and, Stenzel-Poore M. P., (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55, 310-318.
8. Fekety F. R., (1990) Safety of parenteral third-generation cephalosporins. Am. J. Med. 88, 38S-44S.
9. Ganel R., Ho T., Maragakis N. J., Jackson M., Steiner J. P., and, Rothstein J. D., (2006) Selective upregulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol. Dis. 21, 556-567.
10. Geng J. X., Cai J. S., Zhang M., Li S. Q., Sun X. C., Xian X. H., Hu Y. Y., Li W. B., and, Li Q. J., (2008) Antisense oligodeoxynucleotides of glial glutamate transporter-1 inhibits the neuro-protection of cerebral ischemic preconditioning in rats. Sheng Li Xue Bao 60, 497-503.
11. Harvey B. K., Airavaara M., Hinzman J., Wires E. M., Chiocco M. J., Howard D. B., Shen H., Gerhardt G., Hoffer B. J., and, Wang Y., (2011) Targeted over-expression of glutamate transporter 1 (GLT-1) reduces ischemic brain injury in a rat model of stroke. PLoS ONE 6, e22135.
12. Inui T., Alessandri B., Heimann A., Nishimura F., Frauenknecht K., Sommer C., and, Kempski O., (2013) Neuroprotective effect of ceftriaxone on the penumbra in a rat venous ischemia model. Neuroscience 242, 1-10.
13. Kato H., Liu Y., Araki T., and, Kogure K., (1991) Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res. 553, 238-242.
14. Ketheeswaranathan P., Turner N. A., Spary E. J., Batten T. F., McColl B. W., and, Saha S., (2011) Changes in glutamate transporter expression in mouse forebrain areas following focal ischemia. Brain Res. 1418, 93-103.
15. Kim S. Y., and, Jones T. A., (2013) The effects of ceftriaxone on skill learning and motor functional outcome after ischemic cortical damage in rats. Restor. Neurol. Neurosci. 31, 87-97.
16. Kim K., Lee S. G., Kegelman T. P., et al. (2011) Role of excitatory amino acid transporter-2 (EAAT2) and glutamate in neurodegeneration: opportunities for developing novel therapeutics. J. Cell. Physiol. 226, 2484-2493.
17. Kitagawa K., Matsumoto M., Tagaya M., et al. (1990) 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528, 21-24.
18. Lipski J., Wan C. K., Bai J. Z., Pi R., Li D., and, Donnelly D., (2007) Neuroprotective potential of ceftriaxone in in vitro models of stroke. Neuroscience 146, 617-629.
19. Liu A. J., Hu Y. Y., Li W. B., Xu J., and, Zhang M., (2011) Cerebral ischemic pre-conditioning enhances the binding characteristics and glutamate uptake of glial glutamate transporter-1 in hippocampal CA1 subfield of rats. J. Neurochem. 119, 202-209.
20. Liu Y. X., Zhang M., Liu L. Z., Cui X., Hu Y. Y., and, Li W. B., (2012) The role of glutamate transporter-1a in the induction of brain ischemic tolerance in rats. Glia 60, 112-124.
21. Mitani A., and, Tanaka K., (2003) Functional changes of glial glutamate transporter GLT-1 during ischemia: an in vivo study in the hippocampal CA1 of normal mice and mutant mice lacking GLT-1. J. Neurosci. 23, 7176-7182.
22. Namura S., Maeno H., Takami S., Jiang X. F., Kamichi S., Wada K., and, Nagata I., (2002) Inhibition of glial glutamate transporter GLT-1 augments brain edema after transient focal cerebral ischemia in mice. Neurosci. Lett. 324, 117-120.
23. Ouyang Y. B., Voloboueva L. A., Xu L. J., and, Giffard R. G., (2007) Selective dysfunction of hippocampal CA1 astrocytes contributes to delayed neuronal damage after transient forebrain ischemia. J. Neurosci. 27, 4253-4260.
24. Pulsinelli W. A., and, Brierley J. B., (1979) A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10, 267-272.
25. Raghavendra Rao V. L., Rao A. M., Dogan A., Bowen K. K., Hatcher J., Rothstein J. D., and, Dempsey R. J., (2000) Glial glutamate transporter GLT-1 down-regulation precedes delayed neuronal death in gerbil hippocampus following transient global cerebral ischemia. Neurochem. Int. 36, 531-537.
26. Rao V. L., Dogan A., Todd K. G., Bowen K. K., Kim B. T., Rothstein J. D., and, Dempsey R. J., (2001) Antisense knockdown of the glial glutamate transporter GLT-1, but not the neuronal glutamate transporter EAAC1, exacerbates transient focal cerebral ischemia-induced neuronal damage in rat brain. J. Neurosci. 21, 1876-1883.
27. Rothman S. M., and, Olney J. W., (1986) Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann. Neurol. 19, 105-111.
28. Rothstein J. D., Dykes-Hoberg M., Pardo C. A., et al. (1996) Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16, 675-686.
29. Rothstein J. D., Patel S., Regan M. R., et al. (2005) Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature. 433, 73-77.
30. Suchak S. K., Baloyianni N. V., Perkinton M. S., Williams R. J., Meldrum B. S., and, Rattray M., (2003) The 'glial' glutamate transporter, EAAT2 (Glt-1) accounts for high affinity glutamate uptake into adult rodent nerve endings. J. Neurochem. 84, 522-532.
31. Swanson R. A., Ying W., and, Kauppinen T. M., (2004) Astrocyte influences on ischemic neuronal death. Curr. Mol. Med. 4, 193-205.
32. Szatkowski M., Barbour B., and, Attwell D., (1990) Non-vesicular release of glutamate from glial cells by reversed electrogenic glutamate uptake. Nature 348, 443-446.
33. Tanaka K., Watase K., Manabe T., et al. (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 276, 1699-1702.
34. Thöne-Reineke C., Neumann C., Namsolleck P., et al. (2008) The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. J. Hypertens. 26, 2426-2435.
35. Torp R., Arvin B., Le Peillet E., Chapman A. G., Ottersen O. P., and, Meldrum B. S., (1993) Effect of ischaemia and reperfusion on the extra- and intracellular distribution of glutamate, glutamine, aspartate and GABA in the rat hippocampus, with a note on the effect of the sodium channel blocker BW1003C87. Exp. Brain Res. 96, 365-376.
36. Verma R., Mishra V., Sasmal D., and, Raghubir R., (2010) Pharmacological evaluation of glutamate transporter 1 (GLT-1) mediated neuroprotection following cerebral ischemia/reperfusion injury. Eur. J. Pharmacol. 638, 65-71.
37. Yang X., He Z., Zhang Q., et al. (2012) Pre-Ischemic treadmill training for prevention of ischemic brain injury via regulation of glutamate and its transporter GLT-1. Int. J. Mol. Sci. 13, 9447-9459.
38. Yeh T. H., Hwang H. M., Chen J. J., Wu T., Li A. H., and, Wang H. L., (2005) Glutamate transporter function of rat hippocampal astrocytes is impaired following the global ischemia. Neurobiol. Dis. 18, 476-483.
39. Zhang M., Li W. B., Geng J. X., Li Q. J., Sun X. C., Xian X. H., Qi J., and, Li S. Q., (2007) The upregulation of glial glutamate transporter-1 participates in the induction of brain ischemic tolerance in rats. J. Cereb. Blood Flow Metab. 27, 1352-1368.
40. Zhang M., Li W. B., Liu Y. X., Liang C. J., Liu L. Z., Cui X., Gong J. X., Gong S. J., Hu Y. Y., and, Xian X. H., (2011) High expression of GLT-1 in hippocampal CA3 and dentate gyrus subfields contributes to their inherent resistance to ischemia in rats. Neurochem. Int. 59, 1019-1028.